From a Punjab-based entrepreneurial venture to an NSE-listed animal healthcare and nutrition company
By The Worldonomics Times
India’s agricultural economy is supported by millions of livestock farmers whose livelihoods depend on animal health, productivity and milk production. Within this ecosystem, animal nutrition has emerged as an increasingly important business opportunity. Ajooni Biotech Limited, headquartered in Mohali, Punjab, has built its business around this opportunity, developing products focused on cattle feed, feed supplements and animal healthcare.
The company traces its origins to 17 February 2010, when it was incorporated as Ajooni Biotech Private Limited at Chandigarh. It was subsequently converted into a public limited company in 2017, with the name changed to Ajooni Biotech Limited on 27 September 2017.
From a Family Enterprise to a Growing Corporate Business
The company’s journey began with an entrepreneurial initiative led by Gurmeet Singh, who started sourcing raw materials, manufacturing cattle feed and feed supplements and selling these products to customers. His son, Jasjot Singh, later joined the business and helped expand the scale and scope of operations.
This evolution from a family-led enterprise into a professionally structured public company reflects a broader story unfolding across India’s agricultural and rural economy. Businesses that understand local requirements and develop specialised products can gradually create organised supply chains and expand their market reach.
Ajooni’s principal business is centred on manufacturing, processing and supplying cattle feed, cattle-feed nutrients and animal healthcare supplements. The company’s product portfolio has included cattle feed, cattle-feed chips, camel feed, cotton oil cake, mustard oil cake and various feed supplements.
Focus on Livestock Productivity
Ajooni’s business model is based on a straightforward economic proposition: better animal nutrition can contribute to improved livestock productivity and potentially better returns for dairy farmers.
The company’s stated mission is to develop cost-effective solutions aimed at improving animal productivity and milk yield while providing quality products and value to customers. Its long-term vision is to become a leading provider of compounded animal feed and feed supplements in India.
This focus becomes particularly relevant in a country where dairy farming is deeply connected with rural household income. For many farmers, livestock is not simply an agricultural asset but an important source of recurring income.
Emphasis on Quality and Technology
Ajooni has highlighted quality standards and technology as important components of its manufacturing strategy. The company states that it is registered with the Department of Dairy Development, Government of Punjab, and has operated with ISO 9001:2015 and GMP certifications, while manufacturing ISI-marked animal feed.
The company has also highlighted the use of ERP systems, PLC-based production controls and modern logistics systems. Its annual reports describe research and development as an important area, particularly for improving product yields, process efficiencies and developing cost-effective solutions.
Such investments are increasingly important as India’s animal-feed industry moves from fragmented and largely unorganised operations towards more standardised manufacturing and quality systems.
Entering the Capital Market
One of the most significant milestones in Ajooni Biotech’s corporate journey was its entry into the capital market.
The company came out with its IPO on the NSE Emerge platform in December 2017. This provided the business with access to public-market capital and increased its visibility among investors.
The next major milestone came in May 2021, when Ajooni Biotech migrated from NSE Emerge to the main board of the National Stock Exchange. This transition represented an important step in the company’s evolution from an SME-market participant into a company operating on the main exchange platform.
For India’s growing businesses, the journey from private enterprise to SME listing and eventually to the main board demonstrates how capital markets can become an important component of long-term corporate development.
Building a Distribution Ecosystem
Ajooni has sought to develop its business beyond manufacturing by creating a distribution network and serving institutional as well as farmer-oriented markets.
The company’s annual report states that it has supplied products to leading organisations including IFFCO Kisan, Mother Dairy, Paras Dairy and Saahaj Dairy.
Its strategy has also involved developing its own brands and expanding the product range. According to the company, a wider portfolio of innovative products can help strengthen its market position while its distribution network can support geographic expansion.
The company has also identified the largely unorganised nature of the animal-feed industry as both a challenge and an opportunity. Greater regulatory and quality requirements could favour organised manufacturers that have established production standards and certifications.
Opportunities in India’s Animal Nutrition Market
India’s dairy and livestock economy presents a large addressable market for animal nutrition companies. Increasing awareness among farmers about balanced feed, nutritional supplements, animal health and productivity can create opportunities for specialised businesses.
Ajooni’s focus on compounded feed and feed supplements positions it within this broader transition. The company’s strategy combines manufacturing, research, quality control and distribution in an attempt to create a scalable business model.
However, the sector is not without risks. Ajooni’s annual report highlights exposure to fluctuations in raw-material prices, weather conditions, seasonal variations, product-quality risks and supply-chain dependencies.
The Road Ahead
Ajooni Biotech’s journey—from its establishment in 2010 to becoming a public company in 2017, entering NSE Emerge and subsequently migrating to the NSE Main Board—offers an interesting case study of entrepreneurship, rural-market opportunity and capital-market development.
Its story also illustrates the changing nature of India’s agricultural economy. The future of dairy farming is increasingly linked not only to the number of animals but also to productivity, nutrition, scientific management and access to quality inputs.
For Ajooni Biotech, the opportunity lies in continuing to develop innovative and cost-effective animal nutrition solutions while expanding its geographic reach and strengthening relationships with farmers, distributors and institutional customers.
For The Worldonomics Times, Ajooni Biotech represents a wider theme in India’s economic transformation: the rise of specialised enterprises that connect technology, organised manufacturing and rural entrepreneurship.
As India works towards a more productive and sustainable agricultural economy, companies operating at the intersection of livestock, nutrition, technology and rural markets could play an increasingly important role.
Company Snapshot
| Particular | Details |
|---|---|
| Company | Ajooni Biotech Limited |
| Incorporated | 17 February 2010 |
| Original Name | Ajooni Biotech Private Limited |
| Public Limited Company | 27 September 2017 |
| Registered Office | Mohali, Punjab |
| CIN | L85190PB2010PLC040162 |
| Industry | Animal Feed / Animal Health & Nutrition |
| IPO Platform | NSE Emerge |
| IPO Year | 2017 |
| Main Board Migration | NSE, May 2021 |
| NSE Symbol | AJOONI |
| Key Products | Cattle Feed, Feed Supplements, Animal Healthcare Products |
| Website | www.ajoonibiotech.com |
Sources: Company annual reports, IPO documents and publicly available corporate information. This article is intended for editorial and informational purposes and should not be construed as investment advice.
